Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Plos One
|
August 25, 2022
Monitoring of urban ecological environment including air quality using satellite imagery
Yuan Wang, Guoyin Cai, Liuzhong Yang, et al.
Sensors (Basel, Switzerland)
|
July 18, 2019
Detailed Urban Land Use Land Cover Classification at the Metropolitan Scale Using a Three-Layer Classification Scheme
Guoyin Cai, Huiqun Ren, Liuzhong Yang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
January 24, 2022
Molecular Mechanism of Traditional Chinese Ointment of Xuzhou Qufu Shengji in Infected Wounds
Jinhu Shen, Chaoding Li, Lei Zhang, et al.
Molecular Medicine Reports
|
August 24, 2013
miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma
Jipeng Shi, Liuzhong Yang, Tuanjie Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
January 17, 2015
RNF125 is a ubiquitin-protein ligase that promotes p53 degradation
Liuzhong Yang, Bing Zhou, Xiaorui Li, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
July 11, 2013
PSMA7 directly interacts with NOD1 and regulates its function
Liuzhong Yang, Zheng Tang, Huiqiang Zhang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
November 5, 2013
Secretion of intestinal goblet cells: a novel excretion pathway of nanoparticles
Baoquan Zhao, Lan Sun, Wuxu Zhang, et al.
International Journal of Biological Macromolecules
|
September 29, 2024
Bovine serum albumin-bound homologous targeted nanoparticles for breast cancer combinatorial therapy
Caili Chen, Bohong Xie, Shuming Sun, et al.
Cancer Communications (London, England)
|
October 19, 2021
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study
Zhi Peng, Tianshu Liu, Jia Wei, et al.
Cancer Cell
|
April 24, 2026
JYP0322, a highly selective and brain-penetrant ROS1 inhibitor, overcomes ROS1<sup>G2032R</sup> resistance mutation in NSCLC: The first-in-human phase 1 trial
Yuxiang Ma, Jinhui Xue, Fangfang Gao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Plos One
|
August 25, 2022
Monitoring of urban ecological environment including air quality using satellite imagery
Yuan Wang, Guoyin Cai, Liuzhong Yang, et al.
Sensors (Basel, Switzerland)
|
July 18, 2019
Detailed Urban Land Use Land Cover Classification at the Metropolitan Scale Using a Three-Layer Classification Scheme
Guoyin Cai, Huiqun Ren, Liuzhong Yang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
January 24, 2022
Molecular Mechanism of Traditional Chinese Ointment of Xuzhou Qufu Shengji in Infected Wounds
Jinhu Shen, Chaoding Li, Lei Zhang, et al.
Molecular Medicine Reports
|
August 24, 2013
miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma
Jipeng Shi, Liuzhong Yang, Tuanjie Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
January 17, 2015
RNF125 is a ubiquitin-protein ligase that promotes p53 degradation
Liuzhong Yang, Bing Zhou, Xiaorui Li, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
July 11, 2013
PSMA7 directly interacts with NOD1 and regulates its function
Liuzhong Yang, Zheng Tang, Huiqiang Zhang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
November 5, 2013
Secretion of intestinal goblet cells: a novel excretion pathway of nanoparticles
Baoquan Zhao, Lan Sun, Wuxu Zhang, et al.
International Journal of Biological Macromolecules
|
September 29, 2024
Bovine serum albumin-bound homologous targeted nanoparticles for breast cancer combinatorial therapy
Caili Chen, Bohong Xie, Shuming Sun, et al.
Cancer Communications (London, England)
|
October 19, 2021
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study
Zhi Peng, Tianshu Liu, Jia Wei, et al.
Cancer Cell
|
April 24, 2026
JYP0322, a highly selective and brain-penetrant ROS1 inhibitor, overcomes ROS1<sup>G2032R</sup> resistance mutation in NSCLC: The first-in-human phase 1 trial
Yuxiang Ma, Jinhui Xue, Fangfang Gao, et al.
Page
of 2